Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brakenhoff

Showing results (221-230 of 460) with videos related to

Pageof 46
Sort By:
Cancer Immunology, Immunotherapy : CII|January 26, 2020
Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumorsEmma J de Ruiter, Reinout H de Roest, Ruud H Brakenhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant TransformationLeon J Wils, Jos B Poell, Arjen Brink, et al.
European Journal of Clinical Pharmacology|June 22, 2001
An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19W J Tamminga, J Wemer, B Oosterhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinomaN L Van Hal, G A Van Dongen, C B Ten Brink, et al.
Oral Oncology|September 22, 2019
Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclassAnne M van Harten, Jos B Poell, Marijke Buijze, et al.
The Journal of Biological Chemistry|April 25, 2000
The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cellsR Eshel, A Zanin, O Sagi-Assif, et al.
Journal of Proteomics|May 19, 2009
Comparative proteome analysis to explore p53 pathway disruption in head and neck carcinogenesisTieneke B M Schaaij-Visser, Ruud H Brakenhoff, Jeroen W A Jansen, et al.
The Oncologist|December 31, 2011
Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature reviewChristine B Boers-Doets, Joel B Epstein, Judith E Raber-Durlacher, et al.
Journal of Medical Internet Research|July 31, 2024
Physiological Response to the COVID-19 Vaccine: Insights From a Prospective, Randomized, Single-Blinded, Crossover TrialAndjela Markovic, Vladimir Kovacevic, Timo B Brakenhoff, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 21, 2007
DNA quality assessment for array CGH by isothermal whole genome amplificationTineke E Buffart, Marianne Tijssen, Thijs Krugers, et al.
Pageof 46

Showing results (221-230 of 460) with videos related to

Sort By:
Pageof 46
Cancer Immunology, Immunotherapy : CII|January 26, 2020
Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumorsEmma J de Ruiter, Reinout H de Roest, Ruud H Brakenhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant TransformationLeon J Wils, Jos B Poell, Arjen Brink, et al.
European Journal of Clinical Pharmacology|June 22, 2001
An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19W J Tamminga, J Wemer, B Oosterhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinomaN L Van Hal, G A Van Dongen, C B Ten Brink, et al.
Oral Oncology|September 22, 2019
Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclassAnne M van Harten, Jos B Poell, Marijke Buijze, et al.
The Journal of Biological Chemistry|April 25, 2000
The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cellsR Eshel, A Zanin, O Sagi-Assif, et al.
Journal of Proteomics|May 19, 2009
Comparative proteome analysis to explore p53 pathway disruption in head and neck carcinogenesisTieneke B M Schaaij-Visser, Ruud H Brakenhoff, Jeroen W A Jansen, et al.
The Oncologist|December 31, 2011
Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature reviewChristine B Boers-Doets, Joel B Epstein, Judith E Raber-Durlacher, et al.
Journal of Medical Internet Research|July 31, 2024
Physiological Response to the COVID-19 Vaccine: Insights From a Prospective, Randomized, Single-Blinded, Crossover TrialAndjela Markovic, Vladimir Kovacevic, Timo B Brakenhoff, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 21, 2007
DNA quality assessment for array CGH by isothermal whole genome amplificationTineke E Buffart, Marianne Tijssen, Thijs Krugers, et al.
Pageof 46